During the recent years, a new class of therapeutic agents has been introduced for the treatment of psoriasis and psoriatic arthritis. These agents target different inflammatory mediators involved in the pathogenesis of disease. The focus of this article is on the mechanism of action, side effect profile and dosing of the agents currently in use today for the treatment of psoriasis.
|Number of pages||10|
|Journal||Journal of Pakistan Association of Dermatologists|
|Publication status||Published - 01-04-2008|
All Science Journal Classification (ASJC) codes